Abstract
The use of electrotransfer to deliver therapeutic agents such as cytotoxic drugs and nucleic acids to cells and tissues has been successfully developed over the last decade. This strategy is promising for the systemic secretion of therapeutic proteins, vaccination and gene therapy. The safe and efficient use of this physical method for clinical purposes requires knowledge of the mechanisms underlying the DNA electrotransfer and expression phenomena. Despite the fact that the pioneering work on plasmid DNA electrotransfer to cells was initiated 30 years ago, many of the underlying mechanisms remain elucidated. While efficient in vitro, the method faces a lack of efficiency in packed tissues. Until now, the great majority of studies have been performed on cells in 2D cultures in Petri dishes or in suspension. However, these studies cannot get access to the tissue-specific architecture and organization present in 3D living tissues. In this context, 3D cell culture models are more relevant concerning in vivo cell organization since cell-cell contacts are present as well as extracellular matrix. The aim of this review is to describe the relevance of using spheroid as a model to address and improve the electrotransfer processes.
Keywords: 3D, DNA transfer, electropermeabilization, electroporation, model, spheroid.
Current Gene Therapy
Title:Progress and Prospects: The Use of 3D Spheroid Model as a Relevant Way to Study and Optimize DNA Electrotransfer
Volume: 13 Issue: 3
Author(s): Laure Gibot and Marie-Pierre Rols
Affiliation:
Keywords: 3D, DNA transfer, electropermeabilization, electroporation, model, spheroid.
Abstract: The use of electrotransfer to deliver therapeutic agents such as cytotoxic drugs and nucleic acids to cells and tissues has been successfully developed over the last decade. This strategy is promising for the systemic secretion of therapeutic proteins, vaccination and gene therapy. The safe and efficient use of this physical method for clinical purposes requires knowledge of the mechanisms underlying the DNA electrotransfer and expression phenomena. Despite the fact that the pioneering work on plasmid DNA electrotransfer to cells was initiated 30 years ago, many of the underlying mechanisms remain elucidated. While efficient in vitro, the method faces a lack of efficiency in packed tissues. Until now, the great majority of studies have been performed on cells in 2D cultures in Petri dishes or in suspension. However, these studies cannot get access to the tissue-specific architecture and organization present in 3D living tissues. In this context, 3D cell culture models are more relevant concerning in vivo cell organization since cell-cell contacts are present as well as extracellular matrix. The aim of this review is to describe the relevance of using spheroid as a model to address and improve the electrotransfer processes.
Export Options
About this article
Cite this article as:
Gibot Laure and Rols Marie-Pierre, Progress and Prospects: The Use of 3D Spheroid Model as a Relevant Way to Study and Optimize DNA Electrotransfer, Current Gene Therapy 2013; 13 (3) . https://dx.doi.org/10.2174/1566523211313030002
DOI https://dx.doi.org/10.2174/1566523211313030002 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MiR-125b Inhibits Cell Proliferation and Induces Apoptosis in Human
Colon Cancer SW480 Cells <i>via</i> Targeting STAT3
Recent Patents on Anti-Cancer Drug Discovery Acetylation Control of Cancer Cell Metabolism
Current Pharmaceutical Design Proteomic Approaches for the Study of Transgelins as Tumor-associated Proteins and Potential Biomarkers
Current Proteomics Small-molecule Inhibitors of Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinases (TK)
Current Pharmaceutical Design Angiogenesis and Microvasculature in the Female Reproductive Organs: Physiological and Pathological Implications
Current Pharmaceutical Design Connexins as Precocious Markers and Molecular Targets for Chemical and Pharmacological Agents in Carcinogenesis
Current Medicinal Chemistry Update on the Development of microRNA and siRNA Molecules as Regulators of Cell Physiology
Recent Patents on DNA & Gene Sequences Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase
Anti-Cancer Agents in Medicinal Chemistry Flexible Estrogen Receptor Modulators: Synthesis, Biochemistry and Molecular Modeling Studies for 3-Benzyl-4,6-diarylhex-3-ene and 3,4,6-Triarylhex-3-ene Derivatives
Medicinal Chemistry The Transcription Factor ETS-1: Its Role in Tumour Development and Strategies for its Inhibition
Mini-Reviews in Medicinal Chemistry Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy
Current Cancer Drug Targets Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets Inhibitors of HDACs - Effective Drugs Against Cancer?
Current Cancer Drug Targets The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies
Current Vascular Pharmacology MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy
Current Cancer Drug Targets Molecular Treatment of Different Breast Cancers
Anti-Cancer Agents in Medicinal Chemistry Targeting Cytotoxic Conjugates of Somatostatin, Luteinizing Hormone- Releasing Hormone and Bombesin to Cancers Expressing Their Receptors: A “Smarter” Chemotherapy
Current Pharmaceutical Design Editorial: Drug Targets and Biomarkers for Obstetric/Gynecologic/Reproductive Diseases
Current Drug Targets Gonadotropin-Releasing Hormone Receptor Signaling: Biased and Unbiased
Mini-Reviews in Medicinal Chemistry Therapeutic Potential of Targeting PAK Signaling
Anti-Cancer Agents in Medicinal Chemistry